“Cases of Meige’s Syndrome Controlled Following Administration of Low-Dose Botulinum Toxin Type-A: A Serial Case Series”, magna-neurologica, vol. 1, no. 2, pp. 41–43, Jul. 2023, doi: 10.20961/magnaneurologica.v1i2.700.